Ref.: BL-RE-092462Manufacturer ref.: EHVEGFACLX5 5 x 96 tests
€2,955.00 excl. VAT
The Human VEGF-A Cell Lysates ELISA quantitates Hu VEGF-A in human cell or tissue lysates. The assay will exclusively recognize both natural and recombinant Hu VEGF-A. Principle of the method The Human VEGF-A solid-phase sandwich ELISA…
Accession number
P15692
Dose range
8.23 pg/ml to 6.000 pg/ml
Sensitivity of the dosage
10 pg/ml
Calibration range
10 pg/ml to 6.000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
The Human VEGF-A Cell Lysates ELISA quantitates Hu VEGF-A in human cell or tissue lysates. The assay will exclusively recognize both natural and recombinant Hu VEGF-A. Principle of the method The Human VEGF-A solid-phase sandwich ELISA…
The Human VEGF-A Cell Lysates ELISA quantitates Hu VEGF-A in human cell or tissue lysates. The assay will exclusively recognize both natural and recombinant Hu VEGF-A. Principle of the method The Human VEGF-A solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
VEGF (vascular endothelial growth factor), which is a homodimer glycoprotein bound to disulfide involved in 45 kDa angiogenesis, promotes tumour progression and metastases. VEGF has various effects on vascular endothelium, including the ability to promote endothelial cell viability, mitogenesis, chemotaxia and vascular permeability. VEGF's family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and PIGF. The VEGF and its receptor system have proven to be the fundamental regulators of cell signaling of langenogenicity. Most tumours have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine associated with this process. To date, 5 different VEGF isoforms have been described. These isoforms are generated following an alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine kinase flt-1 receptors (VEGFR-1) and flk-1/KDR (VEGFR-2), which were expressed almost exclusively on endothelial cells. VEGF and its high affinity binding receptors, tyrosines kinases FLK1 and FLT1, are considered important for the development of embryonic vasculature. Studies have shown that an alternative form of FLT1 splicing produces a soluble protein, called sFLT1, which binds vascular endothelial growth factor with high affinity, acting as an inhibitor in angiogenesis. High levels of VEGF are associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, skin changes), also known as Crow-Fukase syndrome, which affects several organs of the body.
Sensitivity
Sensitivity of dosage: 10 pg/ml.
Measurement range
Dose range: 8.23 pg/ml to 6.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
The antibody pair provided in this kit recognizes the human VEGF-A.
Species
Species: Human.
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17165599
Specifications
Accession number
P15692
Dose range
8.23 pg/ml to 6.000 pg/ml
Sensitivity of the dosage
10 pg/ml
Calibration range
10 pg/ml to 6.000 pg/ml
Dose
ELISA solid-phase sandwich
Conjugate
Biotin
Product type
Kit ELISA
Protein family
Chemiokine & receptors
Type of sample
Cellular lysates
Specificity
The antibody pair provided in this kit recognizes the human VEGF-A.
Sufficient for
5 x 96 dosages
Target species
Human
For use with (application)
ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses